FindTrial
Sign In

To study whether Idiopathic Intracranial Hypertension( A condition where the pressure of cerebrospinal fluid(CSF) increases without an apparent cause) is associated with any inflammation( by studying the presence of inflammatory markers in serum and CSF.

To assess the levels of cytokines and chemokines in patients of Idiopathic Intracranial Hypertension

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/03/023920
Enrollment
100
Registered
2020-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H471- Papilledema

Interventions

Intervention1: Not Applicable: Not Applicable

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age more than 13 years 2. Fulfilling the 2013- Revised diagostic criteria for IIH

Exclusion criteria

Exclusion criteria: 1. Patients with secondary causes of increased intracranial pressure 2. Patients with with probable medical conditions with increase in cytokine levels- a. Acute or chronic inflammatory diseases, b. Acute or chronic infections c. Sepsis d. Ischemic Heart disease, Diabetes Mellitus, Hypertension 3. Pregnant or lactating women 4. Patients not consenting for the study

Design outcomes

Primary

MeasureTime frame
The expression of Inflammatory cytokines will be observed in serum and CSF samples of patients with IIH.Timepoint: The expression of Inflammatory cytokines will be observed in serum and CSF samples of patients with IIH as soon as the requirement of a single kit will be fulfilled.—

Secondary

MeasureTime frame
Comparison of inflammatory markers with various clinical parameters.Timepoint: After the collection of all the samples (3 years)—

Countries

India

Contacts

Public ContactAastha Takkar Kapila

Post Graduate Institute of medical education and Research (PGIMER)

draastha49@yahoo.com7087006691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026